Company intelligence / Profile preview

Fertigo Medical

Zichron Yaakov, Haifa District, Israelfertigo-medical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Fertigo Medical has completed preclinical studies demonstrating that its real-time uterine monitoring technology provides comparable estimates of endometrial status to traditional methods. Ongoing clinical trials are underway to validate the approach in human IVF patients.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapyAI-based diagnostic tool
Industry: Physiological Monitoring

Drug pipeline

3 assets

ProSense

Commercial

Indications: Kidney cancer, Liver cancer

2 more assets in the full pipeline.

Request access →

Partnerships

Israeli Innovation Authority funding support ("Office of the Chief Scientist")

Beyond the preview

Go deeper on Fertigo Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fertigo Medical.

Explore the full profile